Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
35
ALLE Quote, Financials, Valuation and Earnings
Last price:
$128.31
Seasonality move
:
4.28%
Day range:
$128.01 - $131.05
52-week range:
$113.27 - $156.10
Dividend yield:
1.52%
P/E ratio:
18.81x
P/S ratio:
2.98x
P/B ratio:
7.38x
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
-4.77%
Market cap:
$11.1B
Revenue:
$3.8B
EPS (TTM):
$6.82
Analysts' Opinion
-
Consensus RatingAllegion PLC has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $141.94, Allegion PLC has an estimated upside of 10.64% from its current price of $128.29.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $110.00 representing 14.26% downside risk from its current price of $128.29.
Fair Value
-
According to the consensus of 7 analysts, Allegion PLC has 10.64% upside to fair value with a price target of $141.94 per share.
ALLE vs. S&P 500
-
Over the past 5 trading days, Allegion PLC has overperformed the S&P 500 by 2.54% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Allegion PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Allegion PLC has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Allegion PLC reported revenues of $945.6M.
Earnings Growth
-
Allegion PLC has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Allegion PLC reported earnings per share of $1.65.
Enterprise value:
12.6B
EV / Invested capital:
3.59x
Price / LTM sales:
2.98x
EV / EBIT:
15.69x
EV / Revenue:
3.33x
PEG ratio (5yr expected):
1.64x
EV / Free cash flow:
21.56x
Price / Operating cash flow:
19.28x
Enterprise value / EBITDA:
13.66x
Gross Profit (TTM):
$1.7B
Return On Assets:
13.08%
Net Income Margin (TTM):
15.84%
Return On Equity:
41.69%
Return On Invested Capital:
16.6%
Operating Margin:
19.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.3B | $3.7B | $3.8B | $897.4M | $945.6M | |
| Gross Profit | $1.3B | $1.6B | $1.7B | $385.3M | $416.7M | |
| Operating Income | $586.4M | $715.9M | $780.7M | $167.2M | $184.6M | |
| EBITDA | $688.3M | $821.9M | $919.8M | $187.7M | $217.2M | |
| Diluted EPS | $5.18 | $6.12 | $6.82 | $1.34 | $1.65 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1.1B | $1.2B | $1.4B | $1.4B | |
| Total Assets | $3.1B | $3.1B | $4B | $4.3B | $4.5B | |
| Current Liabilities | $521.5M | $601.2M | $703.6M | $1.1B | $696.9M | |
| Total Liabilities | $2.2B | $2.3B | $3B | $3B | $3B | |
| Total Equity | $832.6M | $762.4M | $944.5M | $1.3B | $1.5B | |
| Total Debt | $1.4B | $1.4B | $2.1B | $2B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $459.5M | $600.6M | $675M | $219.5M | $219M | |
| Cash From Investing | -$994.1M | -$129.1M | -$228.4M | -$45.7M | -$38.2M | |
| Cash From Financing | $437M | -$298.7M | -$394.5M | -$78.8M | -$541.8M | |
| Free Cash Flow | $395.5M | $516.4M | $582.9M | $196M | $194.9M | |
ALLE
Sector
Market Cap
$11.1B
$618.1M
Price % of 52-Week High
82.19%
74.85%
Dividend Yield
1.52%
0%
Shareholder Yield
3.45%
2.42%
1-Year Price Total Return
-4.77%
-6%
Beta (5-Year)
1.106
0.886
Dividend yield:
1.52%
Annualized payout:
$1.92
Payout ratio:
27.95%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$129.06
200-day SMA
Sell
Level
$133.10
Bollinger Bands (100)
Sell
Level
127.78 - 138.96
Chaikin Money Flow
Buy
Level
69.3M
20-day SMA
Buy
Level
$127.68
Relative Strength Index (RSI14)
Sell
Level
49.11
ADX Line
Buy
Level
12.2
Williams %R
Neutral
Level
-44.4211
50-day SMA
Sell
Level
$129.53
MACD (12, 26)
Buy
Level
0.09
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
99M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.4588)
Buy
CA Score
(Annual)
Level (-0.1327)
Buy
Beneish M-Score
(Annual)
Level (-2.5454)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.0136)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
Stock Forecast FAQ
In the current month, ALLE has received 1 Buy ratings 6 Hold ratings, and 0 Sell ratings. The ALLE average analyst price target in the past 3 months is $141.94.
-
Where Will Allegion PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Allegion PLC share price will rise to $141.94 per share over the next 12 months.
-
What Do Analysts Say About Allegion PLC?
Analysts are divided on their view about Allegion PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Allegion PLC is a Sell and believe this share price will drop from its current level to $110.00.
-
What Is Allegion PLC's Price Target?
The price target for Allegion PLC over the next 1-year time period is forecast to be $141.94 according to 7 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is ALLE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Allegion PLC is a Hold. 6 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ALLE?
You can purchase shares of Allegion PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Allegion PLC shares.
-
What Is The Allegion PLC Share Price Today?
Allegion PLC was last trading at $128.31 per share. This represents the most recent stock quote for Allegion PLC. Yesterday, Allegion PLC closed at $128.29 per share.
-
How To Buy Allegion PLC Stock Online?
In order to purchase Allegion PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
74
SLNO alert for Mar 29
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
